The SilverHawk™ Plaque Excision System is an
FDA-cleared device for the treatment of de novo and restenotic
lesions in the peripheral arteries.
Plaque excision is a minimally invasive
procedure performed through a tiny puncture site in the leg or
arm. The SilverHawk System uses a tiny rotating blade to shave
away plaque from inside the artery. As it is excised, the plaque
collects in the tip of the device and then is removed from the
patient.
In hospitals across the U.S., plaque excision
has helped alleviate severe leg pain for thousands of patients. In
many cases, it has successfully saved the legs of patients who
were scheduled for limb amputation after other peripheral
interventions failed.

The SilverHawk™ Plaque Excision System is a
device used to remove plaque that commonly blocks arteries and
interrupts blood flow. Unlike stenting and other methods of
opening the artery, the SilverHawk removes the source of the
problem – plaque build-up – instead of simply compressing it
against the vessel wall. Hundreds of milligrams of plaque are
routinely removed from arteries treated with the SilverHawk.
Multiple vessels and lesions can be treated with a single device,
which reduces procedure time and cost. Early clinical data from a
multi-center study and several single-center studies indicate
positive safety and efficacy rates.
The SilverHawk System is capable of removing
significant amounts of plaque without overstretching the artery
and causing barotrauma. By removing plaque, the SilverHawk creates
a large channel for adequate blood flow without stretching the
vessel wall.